FROM INVENTION TO SUCCESS
About Turon Medtech
Turon MedTech is the inventor of Cytoguide – the world’s first automated positioning tool for breast biopsy. We are also the leading independent provider of stereotactic instruments for breast biopsy. The company is characterized by long-term thinking, experience, expertise, flexibility, high customer service, fast delivery, close collaboration with customers and suppliers, as well as customer driven and efficient development.
Certifications
At Turon Medtech, quality and safety are at the core of everything we do. Our products are developed, manufactured, and documented in strict accordance with internationally recognized standards for medical devices.
We are proud to be certified according to:
From Invention to Innovation
Turon MedTech’s journey in Breast Biopsy Technology
Since the mid-1980s, Turon MedTech has been at the forefront of breast biopsy innovation. Beginning with the development of Cytoguide—the world’s first automated positioning tool for breast biopsy—the company has consistently advanced medical technology. Through strategic collaborations with global partners and a commitment to customer-driven development, Turon MedTech has achieved significant milestones, including the recent attainment of the MDR Certificate. Explore the timeline below to discover the key events that have shaped Turon MedTech’s legacy in medical device innovation.
1985
The begining
Mammography is introduced as a screening program in Sweden. Björn Ericson begins the development of Cytoguide.
1986
Prototype
The first prototype of Cytoguide is presented. The system is further developed in cooperation with Philips in Germany.
1987
University Hospital in Kiel
Cytoguide is put into use at the University Hospital in Kiel and then begins to be marketed and sold globally via Philips.
1990
Planmed
Planmed becomes a customer of Turon MedTech and has since been one of the company’s most loyal customers.
1994
Toshiba
Toshiba becomes a customer of Turon MedTech.
2000
Turon Medtech AB
Turon Medtech AB breaks out from Turon AB under Jonas Lindquist’s management.
2008
Medifuture
Collaboration begins with the Korean mammography manufacturer, Medifuture.
2009
Siemens
Cooperation with Siemens begins.
2012
Allengers and Adani
Allengers and Adani become customers of Turon MedTech.
2015
Upgrade
Cytoguide is upgraded with various additional features such as light indication for ease of use.
2017
Tomosynthesis guided biopsy
Cytoguide updated for tomosynthesis guided biopsy.
Quick mount adapter for fully transparent tomosynthesis guided Fine and Core needle breast biopsy.
2017
Inhouse 3D-printing
Inhouse 3D-printing for rapid prototype development.
SLA- and FDM-printing.
2018
Vacuum assisted biopsy
Full support for lateral and vertical vacuum assisted biopsy. Specific adaption with optimized design for all major vacuum assisted needles.
2019
Lateral holder
Introducing lateral holder for fine and core needle breast biopsy.
2020
Updated hand control
New tactile feedback buttons. Updated hand control for manual movement with tactile feedback in buttons.
2021
Updated hand control
Upgraded electronics in the Cytoguide, electronic box and hand control.
2023
R&D office
Opened R&D office in Halmstad.
2024
Cytosafe
Cytosafe – We´re developing a new needle holder based on feedback from customers and market research. The new product is intended to simplify the use for the customer, both related to maintaining sterility and with using the correct gauge.
